Category:Monoclonal antibodies
From WikiMD's Wellness Encyclopedia
Subcategories
This category has the following 2 subcategories, out of 2 total.
Pages in category "Monoclonal antibodies"
The following 200 pages are in this category, out of 506 total.
(previous page) (next page)A
- Abciximab
- Abituzumab
- ABP 501
- Abrilumab
- Actoxumab
- Adalimumab
- ADC-3680
- Adecatumumab
- Aducanumab
- Aducanumab-avwa
- Afelimomab
- Afucosylated monoclonal antibodies
- AGS67E
- AK002
- Alacizumab pegol
- Alemtuzumab
- Alirocumab
- Altumomab pentetate
- Amatuximab
- Anatumomab mafenatox
- Andecaliximab
- Anifrolumab
- Anifrolumab-fnia
- Ansuvimab
- Ansuvimab-zykl
- Anti-CD3 monoclonal antibody
- Anti-IL-6
- Antibody-drug conjugate
- Apolizumab
- ARGX-109
- Ascrinvacumab
- Aselizumab
- Atoltivimab
- Atoltivimab, maftivimab, and odesivimab-ebgn
- Atoltivimab/maftivimab/odesivimab
- AVE-1642
- Axatilimab
B
- Bamlanivimab/etesevimab
- BAN2401
- Bapineuzumab
- Bavituximab
- Bectumomab
- Belimumab
- Benralizumab
- BerEp4
- Bertilimumab
- Besilesomab
- Bezlotoxumab
- Biciromab
- BIIB033
- Bimagrumab
- Bimekizumab
- Bivatuzumab
- Bleselumab
- Blosozumab
- Bococizumab
- Brazikumab
- Brentuximab vedotin
- Briakinumab
- Briumvi
- Brolucizumab
- Brolucizumab-dbll
- Brontictuzumab
- Burosumab
C
- Camrelizumab
- Cantuzumab
- Cantuzumab mertansine
- Cantuzumab ravtansine
- Caplacizumab
- Caplacizumab-yhdp
- Carotuximab
- Casirivimab/imdevimab
- Catumaxomab
- Cedelizumab
- Certolizumab
- Certolizumab pegol
- Chemically linked Fab
- Chimeric antibody
- Cilgavimab/Tixagevimab
- Cinqair
- Cirmtuzumab
- Citatuzumab
- Cixutumumab
- Clazakizumab
- Clazakizumab (version 2)
- Clenoliximab
- Clevegen
- Clivatuzumab tetraxetan
- Conatumumab
- Crenezumab
- Crizanlizumab
- Crizanlizumab-tmca
D
- Dacetuzumab
- Dacliximab
- Daclizumab
- Dalotuzumab
- Dapirolizumab pegol
- Daratumumab
- Demcizumab
- Denintuzumab mafodotin
- Denosumab
- Detumomab
- Developmental Studies Hybridoma Bank
- Dinutuximab
- Dinutuximab beta
- Diridavumab
- Domagrozumab
- Donanemab
- Drozitumab
- Duligotumab
- Duligotuzumab
- Dupilumab
- Durvalumab
- Dusigitumab
- Duvortuxizumab
E
- Ecromeximab
- Eculizumab
- Edobacomab
- Edrecolomab
- Efungumab
- Eldelumab
- Elipovimab
- Elsilimomab
- Emactuzumab
- Emapalumab
- Emapalumab-lzsg
- Emibetuzumab
- Emicizumab
- Emtansine
- Enfortumab vedotin
- Enfortumab vedotin-ejfv
- Template:Engineered antibodies
- Enoblituzumab
- Enokizumab
- Enoticumab
- Ensituximab
- Epratuzumab
- Eptinezumab
- Erelzi
- Erenumab
- Erenumab-aooe
- Erlizumab
- Ertumaxomab
- Etrolizumab
- Evinacumab
- Evinacumab-dgnb
- Evolocumab
- Exbivirumab
